If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Rearrangements involving ETV6 and ABL1 are more commonly observed in Philadelphia-negative
myeloproliferative neoplasms, with rare reports in patients with AML or ALL. We present
the evaluation of a 12-year old male who presented with acute fever and a CBC which
showed progressive anemia. Bone marrow analysis identified precursor B-cell ALL. Chromosome,
fluorescence in situ hybridization (FISH) and SNP CMA analyses were performed on cells from a bone marrow
aspirate. Chromosome analysis identified a slightly atypical hyperdiploid ALL clone
[51,XY,+X,+15,+17,+21,+21]. Interphase FISH showed two signals for chromosomes 4 and
10, four RUNX1 signals, negativity for KMT2A rearrangement and BCR/ABL1 or ETV6/RUNX1 fusions. However, one ETV6 signal was clearly diminished in addition to a deletion of one ASS1 9q34 probe signal.
We have previously associated the latter with either ABL1 or NUP214 9q34 gene fusions typically seen in T-ALL, which can be resolved by microarray, RNA
sequencing, or dual-color FISH. A SNP microarray confirmed the chromosome gains observed
in the karyotype and revealed that the ASS1 deletion included partial deletion of ABL1 distally but no specific gene proximally, suggesting an ectopic gene insertion, resulting
in a probable ABL1 fusion. The array was notable for a contiguous terminal deletion and proximal duplication
of 12p. Although ETV6 was located in the deleted interval, there was an increased copy number for ∼90%
of the gene. This was interpreted as strong evidence of ETV6 insertion into chromosome 9. Since both ETV6 and ABL1 have opposite orientation to the centromeres, an in-frame fusion gene requires three
chromosome breaks to be generated (limiting the incidence of this fusion) and the
putative insertion mechanism in this clone would be consistent with that etiology.
An ETV6/ABL1 fusion within 9q34 was confirmed by metaphase FISH and RNA sequencing.
This report highlights the utility of a multidiscipline approach to leukemia evaluation.
To read this article in full you will need to make a payment